SOUTH Africa’s medicines regulator, the South African Health Products Regulatory Authority (SAHPRA) has approved a 4-in-1 fixed dose combination of four antiretroviral treatments namely abacavir, lamivudine, lopinavir and ritonavir which is meant for infants and young children with HIV. By Kudakwashe Pembere The sweet-tasting, and heat stable was developed by Cipla Limited and the not-for-profit Drugs for Neglected Diseases Initiative (DNDi). “This new formulation represents a significant improvement over protease inhibitor-containing paediatric ARV formulations that have been used in South Africa for decades. It does not require refrigeration, has a…
Read MoreSouth Africa approves 4-in-1 HIV Antiretroviral treatment
